ACP advises all adults 75 or older get a protein subunit RSV vaccine

The American College of Physicians (ACP) issued updated vaccine practice points for physicians that advise adults aged 75 or ...
Infectious Disease Advisor

Immunocompromised Status Linked to High COVID-19 Mortality

Immunocompromised status remains a significant risk factor for in-hospital mortality in COVID-19, particularly among patients with pneumonia.
European Medical Journal

COVID-19 Vaccination Recommended for Immunocompromised Patients

New guidance backs seasonal COVID-19 vaccination in immunocompromised patients. Read more on timing and risk groups.
Healio

Pritelivir shows promise against HSV in immunocompromised patients

Pritelivir, an investigational antiviral drug for herpes simplex virus, demonstrated “superior efficacy” in healing lesions ...
Physician's Weekly

Q&A: Tailoring Antibiotic Therapy for Ventilator-Associated Pneumonia

Clinicians should treat ventilator‑associated pneumonia (VAP) until the infection is controlled and the patient is clearly ...

Blocking both drug-resistant bacteria and influenza with a broad-spectrum infection prevention approach

Secondary infections caused by bacteria or viruses during hospital care remain a long-standing global challenge, despite advances in modern medicine. In particular, mixed bacterial-viral infections in ...